Keith A A Fox Selected Research

Aspirin (Acetylsalicylic Acid)

12/2022	Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial.
12/2022	Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry.
11/2022	Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial.
10/2022	Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial.
1/2022	Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis.
1/2022	Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.
8/2021	Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease.
1/2021	Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial.
1/2021	Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
1/2021	Response by Fox to Letter Regarding Article, "The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease".

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keith A A Fox Research Topics

Disease

130	Hemorrhage 12/2022 - 09/2002
123	Stroke (Strokes) 12/2022 - 10/2003
111	Acute Coronary Syndrome 08/2022 - 05/2002
102	Myocardial Infarction 12/2022 - 05/2002
83	Atrial Fibrillation 01/2022 - 01/2005
49	Embolism (Embolus) 01/2022 - 06/2008
40	ST Elevation Myocardial Infarction 04/2021 - 08/2002
34	Heart Failure 02/2021 - 09/2002
28	Peripheral Arterial Disease 12/2022 - 05/2007
25	Thrombosis (Thrombus) 01/2022 - 03/2005
25	Unstable Angina 01/2020 - 08/2002
24	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 02/2002
17	Vascular Diseases (Vascular Disease) 10/2022 - 06/2010
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 04/2003
14	Ischemic Stroke 01/2022 - 05/2007
12	Ischemia 01/2019 - 07/2004
11	Non-ST Elevated Myocardial Infarction 04/2021 - 08/2002
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2021 - 04/2006
8	Atherosclerosis 01/2022 - 09/2009
8	Coronary Disease (Coronary Heart Disease) 01/2019 - 09/2004
7	Diabetes Mellitus 02/2021 - 02/2009
7	Inflammation (Inflammations) 04/2016 - 01/2003
6	Transient Ischemic Attack 05/2017 - 01/2005
5	Venous Thromboembolism 01/2022 - 06/2008
5	Hypertension (High Blood Pressure) 02/2021 - 01/2005
5	Body Weight (Weight, Body) 01/2021 - 04/2006
5	Stable Angina 08/2015 - 09/2004
4	Infarction (Infarctions) 01/2018 - 02/2005
3	Venous Thrombosis (Deep-Vein Thrombosis) 11/2018 - 03/2005
3	Carotid Artery Diseases 01/2018 - 01/2018
3	Chest Pain (Chest Pains) 11/2017 - 04/2010
3	Atherosclerotic Plaque (Atheroma) 02/2014 - 08/2003
3	Left Ventricular Dysfunction 07/2011 - 04/2005
3	Necrosis 03/2011 - 01/2004
2	Chronic Renal Insufficiency 08/2022 - 05/2009
2	Thromboembolism 02/2021 - 01/2020
2	Overweight 01/2021 - 01/2017
2	Death (Near-Death Experience) 01/2021 - 04/2013
2	Vascular System Injuries 01/2020 - 05/2002
2	Neoplasms (Cancer) 01/2019 - 01/2016

Drug/Important Bio-Agent (IBA)

90	RivaroxabanIBA 12/2022 - 06/2008
72	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 09/2002
57	Clopidogrel (Plavix)FDA Link 08/2022 - 09/2002
49	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 09/2011
44	Vitamin K FDA Link 10/2021 - 01/2013
34	Factor Xa (Coagulation Factor Xa)IBA 10/2021 - 03/2005
29	AnticoagulantsIBA 01/2022 - 04/2006
21	Prasugrel Hydrochloride FDA Link 08/2022 - 07/2010
16	CreatinineIBA 07/2020 - 11/2002
16	Heparin (Liquaemin)FDA LinkGeneric 01/2011 - 09/2002
16	Enoxaparin (Lovenox)FDA LinkGeneric 09/2010 - 02/2002
13	TroponinIBA 01/2022 - 02/2009
13	Fondaparinux (Arixtra)FDA Link 04/2021 - 03/2005
12	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 08/2022 - 06/2010
11	Factor Xa InhibitorsIBA 01/2022 - 03/2005
10	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2004
10	Pharmaceutical PreparationsIBA 01/2019 - 02/2009
8	omega-Chloroacetophenone (Mace)IBA 10/2022 - 01/2018
8	Troponin IIBA 01/2021 - 03/2011
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 09/2002
7	Glycoproteins (Glycoprotein)IBA 01/2011 - 08/2002
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020 - 04/2006
6	C-Reactive ProteinIBA 07/2017 - 01/2004
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2015 - 06/2004
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2012 - 09/2002
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2010 - 08/2003
5	AntithrombinsIBA 02/2021 - 09/2004
5	BradykininIBA 05/2013 - 09/2002
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2012 - 09/2002
4	Thrombin FDA Link 01/2020 - 03/2005
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2017 - 01/2003
4	vorapaxarIBA 01/2017 - 09/2009
4	Blood Glucose (Blood Sugar)IBA 10/2013 - 10/2005
4	ThienopyridinesIBA 03/2010 - 10/2005
3	apixabanIBA 01/2022 - 06/2009
3	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2017
3	Hemoglobins (Hemoglobin)IBA 07/2020 - 09/2010
3	pro-brain natriuretic peptide (1-76)IBA 10/2019 - 11/2016
3	Proton Pump InhibitorsIBA 01/2019 - 10/2015
3	LipidsIBA 01/2017 - 10/2005
3	Cytochrome P-450 CYP2C19IBA 03/2016 - 10/2010
3	Dalteparin (Dalteparin Sodium)FDA Link 02/2012 - 06/2010
3	Nifedipine (Adalat)FDA LinkGeneric 08/2007 - 09/2004
2	N(4)-oleylcytosine arabinosideIBA 02/2021 - 01/2018
2	Pantoprazole (Protonix)FDA LinkGeneric 01/2019 - 01/2019
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2007

Therapy/Procedure

107	Therapeutics 10/2022 - 05/2002
43	Percutaneous Coronary Intervention 08/2022 - 09/2002
11	Stents 03/2020 - 02/2004
9	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 01/2005
8	Surgical Amputation (Amputations) 01/2022 - 07/2010
8	Patient Readmission 11/2019 - 11/2005
7	Conservative Treatment 02/2012 - 07/2008
6	Secondary Prevention 01/2020 - 06/2008
5	Thrombolytic Therapy 11/2017 - 09/2002
3	Polypharmacy 11/2022 - 01/2016
3	Drug Therapy (Chemotherapy) 06/2021 - 02/2010
2	Length of Stay 01/2021 - 04/2003
2	Myocardial Revascularization 01/2020 - 08/2015